Showing 2,041 - 2,060 results of 122,865 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.69s Refine Results
  1. 2041

    Table_5_Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.xlsx by Aleksandra Stanisavljevic (9245209)

    Published 2022
    “…Hypertension, a prominent non-amyloidal CSVD, has been found to increase risk of dementia, but clinical data regarding its effects in CAA patients is controversial. …”
  2. 2042

    DdataSheet_1_Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report.pdf by Martin Kongsbak-Wismann (10821597)

    Published 2021
    “…However, by studying the course of COVID-19 and the immune response against SARS-CoV-2 in a family with a mutated, non-functional vitamin D receptor, we here demonstrate that vitamin D signaling was dispensable for mounting an efficient adaptive immune response against SARS-CoV-2 in this family. …”
  3. 2043

    Decreasing non-cognate ternary complexes by cooperativity increases the efficiency and robustness of duplex formation. by David N. Adamson (208890)

    Published 2011
    “…<p>(A) Simplified topology representations showing the reaction schemes with or without cognate selection and with or without non-cognate exclusion. …”
  4. 2044
  5. 2045
  6. 2046
  7. 2047

    Lipid Droplet-Binding Protein TIP47 Regulates Hepatitis C Virus RNA Replication through Interaction with the Viral NS5A Protein by Dorothee A. Vogt (247917)

    Published 2013
    “…A single point mutation (W9A) in NS5A that disrupts the interaction with TIP47 but preserves proper subcellular localization severely decreased HCV RNA replication. …”
  8. 2048

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…Background<p>The increasing use of non-specific immunoglobulins (NSIGs) and their current shortage show a need for NSIGs’ use prioritization. …”
  9. 2049
  10. 2050
  11. 2051
  12. 2052
  13. 2053
  14. 2054
  15. 2055
  16. 2056

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  17. 2057

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  18. 2058

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  19. 2059

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  20. 2060

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”